Kilitch Drugs (India) Ltd (KILITCH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 189669, "name": "Kilitch Drugs", "stock_name": "Kilitch Drugs", "full_name": "Kilitch Drugs (India) Ltd", "name_url": "stocks-analysis/kilitch-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "133.40", "chg": -5.55, "chgp": "-3.99%", "dir": -1, "prev_price": "138.95", "mcapval": "470.00 Cr", "mcap": "Micro Cap", "scripcode": 524500, "symbol": "KILITCH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE729D01010", "curr_date": "Apr 06", "curr_time": "", "bse_nse_vol": "1.04 lacs", "exc_status": "Active", "traded_date": "Apr 06, 2026", "traded_date_str": "2026 04 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Kilitch Drugs Gains 0.98%: 3 Key Factors Driving the Week’s Recovery", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-098-3-key-factors-driving-the-weeks-recovery-3933402", "imagepath": "", "date": "2026-04-05 14:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Stock hits 52-week low of Rs.127.55 amid downtrend</p>\n <p><strong>30 Mar:</strong> Valuation shifts to attractive despite price weakness</p>\n <p><strong>30 Mar:</strong> MarketsMOJO upgrades rating from Strong Sell to Sell</p>\n <p><strong>01 Apr:</strong> Stock rebounds sharply, gaining 6.90%</p>\n <p><strong>02 Apr:</strong> Continued gains with 1.91% rise</p>\n <p><strong>03 Apr:</strong> Week closes at Rs.138.95, up 0.98%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div..." }, { "title": "Kilitch Drugs (India) Ltd Upgraded to Sell on Improved Valuation Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-upgraded-to-sell-on-improved-valuation-metrics-3926940", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3926940.png", "date": "2026-03-31 08:01:54", "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a significant improvement in its valuation metrics despite ongoing challenges in financial performance and market sentiment. This nuanced shift reflects a more attractive entry point for investors, balanced against persistent operational headwinds and technical weaknesses." }, { "title": "Kilitch Drugs Falls to 52-Week Low of Rs 131 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-falls-to-52-week-low-of-rs131-amid-continued-downtrend-3924026", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_priceRelatedfactors_3924026.png", "date": "2026-03-30 09:51:01", "description": "For the fourth consecutive session, Kilitch Drugs (India) Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 131 on 30 Mar 2026. This marks a significant 14.09% drop over the past four days, underscoring persistent selling pressure despite some recovery in broader market indices." }, { "title": "Kilitch Drugs Valuation Shifts to Attractive Amid Market Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-attractive-amid-market-downturn-3923209", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_valuationdot_3923209.png", "date": "2026-03-30 08:00:16", "description": "Kilitch Drugs (India) Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite recent share price declines. This change reflects evolving market perceptions and relative valuation improvements compared to peers in the Pharmaceuticals & Biotechnology sector." }, { "title": "Why is Kilitch Drugs (India) Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kilitch-drugs-india-ltd-fallingrising-3917601", "imagepath": "", "date": "2026-03-26 01:21:55", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Comparison</strong></p>\n<p>Over the past week, Kilitch Drugs has underperformed the benchmark Sensex index, registering a decline of 4.39% compared to the Sensex’s 1.87% fall. This underperformance extends to the one-month period, where the stock dropped 4.97%, although this was less severe than the Sensex’s 8.51% decline. Year-to-date, Kilitch Drugs has fallen 13.07%, slightly worse than the Sensex’s 11.67% decrease. Over the last year, the stock’s decline of 12.42% notably outpaces the Sensex’s more modest 3.52% fall. However, the longer-term picture remains positive, with Kilitch Drugs delivering a remarkable 100.26% gain over three years and an impressive 273.77% rise over five years, significantly outperforming the Sensex’s respective 30.85% and 55.39..." }, { "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3909636", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3909636.png", "date": "2026-03-24 10:10:41", "description": "Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "What is the bonus history of Kilitch Drugs?", "link": "https://www.marketsmojo.com/news/stocks-in-action/what-is-the-bonus-history-of-kilitch-drugs-3904620", "imagepath": "", "date": "2026-03-20 23:00:54", "description": "Kilitch Drugs has a recent bonus history that includes a 1:1 bonus issue, which is set to take effect on March 24, 2026. This means that for every share held, shareholders will receive an additional share. The record date and ex-date for this bonus issue are both the same, March 24, 2026. If you have any further questions about Kilitch Drugs or its financial activities, feel free to ask!..." }, { "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3888312", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3888312.png", "date": "2026-03-13 10:10:43", "description": "Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3863990", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3863990.png", "date": "2026-03-02 10:10:49", "description": "Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 298, "sid": "189669", "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "25-Mar-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Board Meeting Outcome for Allotment Of Bonus Equity Shares", "datetime": "25-Mar-2026", "details": "Board approved the allotment of bonus equity shares in the ratio of 1:1", "source": "BSE" }, { "caption": "Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "17-Mar-2026", "details": "We hereby inform you that the Company has fixed Tuesday 24th March 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19", "dt": "2019-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26", "dt": "2026-03-24", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25", "dt": "2025-07-15", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

30 Mar: Stock hits 52-week low of Rs.127.55 amid downtrend

30 Mar: Valuation shifts to attractive despite price weakness

30 Mar: MarketsMOJO upgrades rating from Strong Sell to Sell

01 Apr: Stock rebounds sharply, gaining 6.90%

02 Apr: Continued gains with 1.91% rise

03 Apr: Week closes at Rs.138.95, up 0.98%

Week OpenRead full news article

Kilitch Drugs (India) Ltd Upgraded to Sell on Improved Valuation Metrics

2026-03-31 08:01:54

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a significant improvement in its valuation metrics despite ongoing challenges in financial performance and market sentiment. This nuanced shift reflects a more attractive entry point for investors, balanced against persistent operational headwinds and technical weaknesses.

Read full news article

Kilitch Drugs Falls to 52-Week Low of Rs 131 as Sell-Off Deepens

2026-03-30 09:51:01

For the fourth consecutive session, Kilitch Drugs (India) Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 131 on 30 Mar 2026. This marks a significant 14.09% drop over the past four days, underscoring persistent selling pressure despite some recovery in broader market indices.

Read full news article

Kilitch Drugs Valuation Shifts to Attractive Amid Market Downturn

2026-03-30 08:00:16

Kilitch Drugs (India) Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite recent share price declines. This change reflects evolving market perceptions and relative valuation improvements compared to peers in the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Kilitch Drugs (India) Ltd falling/rising?

2026-03-26 01:21:55

Recent Price Performance and Market Comparison

Over the past week, Kilitch Drugs has underperformed the benchmark Sensex index, registering a decline of 4.39% compared to the Sensex’s 1.87% fall. This underperformance extends to the one-month period, where the stock dropped 4.97%, although this was less severe than the Sensex’s 8.51% decline. Year-to-date, Kilitch Drugs has fallen 13.07%, slightly worse than the Sensex’s 11.67% decrease. Over the last year, the stock’s decline of 12.42% notably outpaces the Sensex’s more modest 3.52% fall. However, the longer-term picture remains positive, with Kilitch Drugs delivering a remarkable 100.26% gain over three years and an impressive 273.77% rise over five years, significantly outperforming the Sensex’s respective 30.85% and 55.39...

Read full news article

Kilitch Drugs (India) Ltd is Rated Strong Sell

2026-03-24 10:10:41

Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

What is the bonus history of Kilitch Drugs?

2026-03-20 23:00:54

Kilitch Drugs has a recent bonus history that includes a 1:1 bonus issue, which is set to take effect on March 24, 2026. This means that for every share held, shareholders will receive an additional share. The record date and ex-date for this bonus issue are both the same, March 24, 2026. If you have any further questions about Kilitch Drugs or its financial activities, feel free to ask!...

Read full news article

Kilitch Drugs (India) Ltd is Rated Strong Sell

2026-03-13 10:10:43

Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kilitch Drugs (India) Ltd is Rated Strong Sell

2026-03-02 10:10:49

Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News